A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

2019 ◽  
Author(s):  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Safety And Efficacy

scholarly journals Dupilumab Provides Acceptable Long-Term Safety and Efficacy in Children Aged ≥ 6 to < 12 Years with Uncontrolled, Severe Atopic Dermatitis

2020 ◽  
Vol 4 (6) ◽  
pp. s104
Author(s):  
Michael Cork ◽  
Diamant Thaçi ◽  
Lawrence Eichenfield ◽  
Peter Arkwright ◽  
Zhen Chen ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Safety And Efficacy

Abstract not available.

Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow‐up

2020 ◽  
Vol 45 (6) ◽  
pp. 762-763
Author(s):  
M. Romagnuolo ◽  
L. Angileri ◽  
S. Tavecchio ◽  
A. V. Marzano ◽  
S. Ferrucci
Keyword(s):  
Atopic Dermatitis ◽  
Hiv Infection ◽  
Severe Atopic Dermatitis ◽  
Safety And Efficacy

Treatment of Severe Atopic Dermatitis Patients with Cyclosporin A(CyA): the Long-Term Safety and Efficacy.

1999 ◽  
Vol 61 (3) ◽  
pp. 271-278
Author(s):  
Yumiko KUBOTA ◽  
Shuhei IMAYAMA ◽  
Hiroko MIYAHARA ◽  
Tomoko TANAHASHI ◽  
Yoko UEMURA ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Cyclosporin A ◽  
Severe Atopic Dermatitis ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document